NEWS: The full-text of the abstracts is now available. Click here

 

LATE BREAKING ABSTRACT SUBMISSION

The Scientific Committee welcomes the submission of late breaking abstracts. Only state-of-the-art research with up-to-date results is considered. The selection will be based on scientific quality and novelty of research either in basic or clinical science. Please note that late-breaking abstracts are not a second chance for those who missed the official abstract deadline.

Abstracts should be submitted by September 15, 2018.

To submit a late breaking abstract please contact eugms@aristea.com

INSTRUCTIONS FOR SUBMISSION

The title of the abstract should be printed in initial capital letters followed by lower case.

The name(s) of the Author(s) should be preceded by the initials (please omit titles).
Organization should be abbreviated, with capitalization as in title.

Each contributor has to put each surname first, without abbreviating this to an initial. Also, do not put full capitals to highlight what is the surname, but just use an initial capital.

The submitting author is responsible also for the correct use of initials and surnames of their co-authors

Affiliations: all authors should have an affiliation, at least with a basic entry including the country.

The structure of the abstracts should include an introduction, methods, results and key conclusions.

Abbreviations should be defined by being placed in parentheses immediately after the full word or phrase has been typed for the first time.

No graphs, figures, tables or unusual symbols can be included.

Place citations to references in square brackets, e.g. [1].
If there are references after the abstract, there should also be citations to the refs in the abstract.

Decimal punctuation is with a decimal point (in English), not with comma.

Generic (nonproprietary) names should be used for drugs and substances.

The abstract should not exceed 250 words.

 

ABSTRACT SUBMISSION

The Scientific Committee welcomes the submission of abstracts of original contributions to the Congress.
Abstracts will be reviewed by the Scientific Committee and may be selected for either oral or poster presentation.
Abstracts should be submitted in English.
Please note that abstracts must be submitted through the official online abstract submission system.

CALL FOR ABSTRACT - NEW DEADLINE MAY 31, 2018

Abstracts will be reviewed by the Scientific Committee and may be selected for either oral or poster presentation.

Abstracts should be submitted in English and sent by May 15 May 31, 2018.

Please note that abstracts must be submitted through the official online abstract submission system.

Any Abstract can be modified by clicking on the link found in the confirmation email.

No faxed or e-mailed abstract will be accepted.

Detailed information, guidelines and recommendations for oral or poster presentation, as well as time allotment, date, hour and venue will be sent by e-mail to the registered presenting Author.

At least one Author of accepted abstracts is required to register and pay the registration fee to ensure the rights for the presentation.

EuGMS is unable to support any participation cost related to submitted abstract, including but not limited to registration, travel and accommodation.

BEST ABSTRACTS AWARDS

One of the EuGMS' aims is to encourage and help young practitioners to further their knowledge and the society bestows four Best Abstracts Awards:
two for the best Oral Presentation and two for the best Poster Presentations.
Each winner of the award will receive a prize of €500.

AWARDS for the BEST POSTER on VACCINES & IMMUNISATION (Supported by MSD Vaccines)

This year there will be an additional award given for the Best Poster on Vaccines & Immunisation related topics.

The Academic Board of the EuGMS will choose the three best abstracts from the submissions received. The best poster will receive a prize of €750 with two runners up receiving €500 and €250 respectively.

The awards will be announced during the closing ceremony.

ABSTRACT TOPICS

Authors may submit abstracts related to the following topics:

- Acute care
- Biogerontology and genetics
- Cognition and dementia
- Comorbidity and multimorbidity
- Comprehensive geriatric assessment
- Delirium
- Ethics and end of life care
- Frailty and sarcopenia
- Geriatric education
- Geriatric rehabilitation
- Geriatrics in organ disease
- Longevity and prevention
- Metabolism and nutrition
- Oral and dental health
- Organisation of care and gerotechnology
- Pharmacology
- Pre and post operative care
- Psychiatric symptoms and illnesses
- Urology and continence management
- Vaccines and Immunisation

ABSTRACT KEYWORDS

Authors may choose from one to three keywords:

- Lifestyle intervention (diet, physical activity...)
- Public health intervention
- Health promotion
- Methodological issue
- Personalized medicine
- Prevention and health system
- Prevention and communities and enrironments
- Prevention in vulnerable population (oldest old, minorities, women...)
- Primary care
- Big data, e-health and technologies

 INSTRUCTIONS FOR ELECTRONIC SUBMISSION

The title of the abstract should be printed in initial capital letters followed by lower case.

The name(s) of the Author(s) should be preceded by the initials (please omit titles).
Organization should be abbreviated, with capitalization as in title.

Each contributor has to put each surname first, without abbreviating this to an initial. Also, do not put full capitals to highlight what is the surname, but just use an initial capital.

The submitting author is responsible also for the correct use of initials and surnames of their co-authors

Affiliations: all authors should have an affiliation, at least with a basic entry including the country.

The structure of the abstracts should include an introduction, methods, results and key conclusions.

Abbreviations should be defined by being placed in parentheses immediately after the full word or phrase has been typed for the first time.

No graphs, figures, tables or unusual symbols can be included.

Place citations to references in square brackets, eg [1].
If there are references after the abstract, there should also be citations to the refs in the abstract, and vice versa.

Decimal punctuation is with a decimal point (in English), not with comma.

Generic (nonproprietary) names should be used for drugs and substances.

The abstract should not exceed 250 words.